All-cause Mortality
16
5
5
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.3%
1 terminated out of 16 trials
88.9%
+2.3% vs benchmark
6%
1 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 8 completed trials
Clinical Trials (16)
Human Observatory Study
100-Year Human Aging Study
PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury
The Global Cardiovascular Risk Consortium
Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis
Direct Oral Anticoagulants in Patients with Atrial Fibrillation (DOACs Vs Warfarin)
Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors and Risk of Cardiovascular Events
Emulation of the Moderate Alcohol and Cardiovascular Health Trial (MACH15)
ADL and CONUT for Predicting 1-year Mortality Risk in Older Adults After Hip Fracture
Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs DOACs)
Hyperthyroid Follow-Up Study
Relationship Between Dietary Protein Intake and Fatal and Non-fatal Health Outcomes
Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure
Korea Atherosclerosis Study-3
Effects of Insecticide Treated Bednets on Child Morbidity and Mortality